Impacts of HBsAg Biochemical Forms on the Potencies of the Recombinant Yeast Hepatitis B Vaccines

李津,朱亭玉,孙玉杰,星海,杨云凯,张俊香,唐巧英,赵铠
DOI: https://doi.org/10.3969/j.issn.1005-5673.2002.04.002
2002-01-01
Abstract:For comparing and studying the impacts of the reductive extent of P24 peptide (Sub-P24)of HBsAg and the disulfide-bonded degree of P24 unit of HBsAg on the laboratory potencies of the recombinant yeast hepatitis B vaccines, the percentages of the reduced P24 peptide (Sub-P24) derived from the P24 with the treatment of DTT and boiling and the particle form HBsAg composed of its disulfide-bonded P24 polypeptide unit were detected by silver stained SDS-PAGE and HPLC respectively. The in vivo mouse potency (ED 50) and in vitro relative potency(RP)for 109 lots of the recombinant yeast hepatitis B vaccines were also tested. The influence of proportion of disulfide-bonded particle HBsAg and Sub-P24 on the potency of the vaccines was analyzed. The results show that the vaccine potency is not impacted by the variations of ratio for the Sub-P24 within 5.2%~31% range and the disulfide-bonded HBsAg from 41.9% to 71.8%. The maximum lot-differences of ED 50 and RP are 10.3 and 2.2 folds respectively. It suggests that the disulfide-bonded degree of P24 unit of HBsAg and its reduction of P24 peptide(Sub-P24) did not affect the potencies of the HB vaccines.
What problem does this paper attempt to address?